Community-acquired pneumonia (CAP) is a common illness, with the majority of patients
treated out of the hospital, yet the greatest burden of the cost of care comes from inpatient …

Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality
worldwide, affecting approximately 5.6 million patients annually in the USA, where the …

Community-acquired pneumonia (CAP) is a serious condition associated with significant
morbidity and potential long-term mortality. Although the majority of patients with CAP are …

Community-acquired pneumonia (CAP) is one of the most common infectious diseases
encountered by physicians. Mild or walking pneumonia is treated in the ambulatory setting …

Community-acquired pneumonia (CAP) is a costly disease that is associated with significant
morbidity and mortality. The growing prevalence of this disease has resulted in various …

Community-acquired pneumonia (CAP) is a common disorder that is potentially life-
threatening, especially in older adults and patients with comorbid disease. Despite …

Community-acquired pneumonia (CAP) is a common and serious problem in the United
States, and the sixth leading cause of death in those over age 65. Not only has short-term …

Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality in all
age groups, especially the elderly, which is a patient population that continues to grow …

This article discusses the key clinical aspects of empiric therapy of community-acquired
pneumonia (CAP). Antibiotic selection, severity of CAP, single vs multiple pathogens …

Community-acquired pneumonia continues to be a significant cause of morbidity and
mortality despite broad-spectrum antibiotics and advances in critical care. Frequently, the …